{"id":478,"date":"2020-12-04T15:16:00","date_gmt":"2020-12-04T07:16:00","guid":{"rendered":"http:\/\/localhost\/cellauto\/?p=478"},"modified":"2021-03-12T11:28:51","modified_gmt":"2021-03-12T03:28:51","slug":"%e5%85%b3%e4%ba%8e%e9%80%82%e5%ba%94%e6%80%a7%e5%b9%b3%e5%8f%b0%e8%af%95%e9%aa%8c%e8%ae%be%e8%ae%a1%e7%9a%84%e5%87%a0%e7%82%b9%e6%80%9d%e8%80%83","status":"publish","type":"post","link":"https:\/\/www.cellauto.com\/cellauto\/2020\/12\/04\/478\/","title":{"rendered":"\u5173\u4e8e\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\u8bbe\u8ba1\u7684\u51e0\u70b9\u601d\u8003"},"content":{"rendered":"\n

\u57282020\u5e7411\u67082\u65e5\u7684\u516c\u4f17\u53f7\u6587\u7ae0\u4e2d\uff0c\u6211\u4eec\u63d0\u5230\u4e86FDA\u6b63\u5f0f\u6279\u590d\u745e\u5fb7\u897f\u97e6\u5728COVID-19\u6cbb\u7597\u4e2d\u7684\u5e94\u7528\u3002\u5728\u4e3a\u8be5\u836f\u7684\u6210\u529f\u4e0a\u5e02\u63d0\u4f9b\u5173\u952e\u6570\u636e\u7684NIH\u7684\u7814\u7a76\u4e2d\u4f7f\u7528\u4e86\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\u8bbe\u8ba1\u3002\u90a3\u4e48\u4ec0\u4e48\u662f\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\u8bbe\u8ba1\uff1f\u8fd9\u79cd\u8bd5\u9a8c\u8bbe\u8ba1\u4e0e\u4f20\u7edf\u7684\u968f\u673a\u5bf9\u7167\u7684\u8bbe\u8ba1\u65b9\u6cd5\u53c8\u6709\u54ea\u4e9b\u4e0d\u540c\uff1f\u5728\u4ec0\u4e48\u6761\u4ef6\u4e0b\u4f7f\u7528\u8fd9\u79cd\u8bd5\u9a8c\u8bbe\u8ba1\u6700\u5408\u9002\uff1f\u6211\u4eec\u4eca\u5929\u5c31\u6765\u4e3a\u5927\u5bb6\u6df1\u5165\u5256\u6790\u4e00\u4e0b\u3002<\/p>\n\n\n\n

\u5728\u8fc7\u53bb\u768420~30\u5e74\u4e2d\uff0c\u9002\u5e94\u6027\u4e34\u5e8a\u8bbe\u8ba1\u4e00\u76f4\u662f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u70ed\u70b9\u3002\u9002\u5e94\u6027\u8bbe\u8ba1\u5177\u6709\u8bbe\u8ba1\u7075\u6d3b\u3001\u8282\u7ea6\u6210\u672c\u3001\u7f29\u77ed\u7814\u53d1\u65f6\u95f4\u548c\u52a0\u5feb\u533b\u836f\u4ea7\u54c1\u4e0a\u5e02\u7b49\u4f18\u52bf\uff0c\u8fd9\u4e9b\u4f18\u52bf\u4e3a\u9002\u5e94\u6027\u8bbe\u8ba1\u7684\u5e94\u7528\u63d0\u4f9b\u4e86\u7406\u8bba\u57fa\u7840\u3002\u5728\u8fc7\u53bb10\u591a\u5e74\u95f4\uff0c\u9010\u6e10\u5f97\u5230\u5305\u62ecFDA\u3001EMA\u7b49\u4e3b\u8981\u76d1\u7ba1\u673a\u6784\uff0c\u5b66\u672f\u7814\u7a76\u673a\u6784\u548c\u4e0a\u5e02\u540e\u536b\u751f\u6280\u672f\u8bc4\u4ef7\u673a\u6784\u7684\u5927\u529b\u652f\u6301\u548c\u63a8\u5e7f\u5e94\u7528\u30022006\u5e74\u7f8e\u56fdFDA\u542f\u52a8\u4e86\u4e00\u9879\u5173\u952e\u8def\u5f84\u5021\u8bae\uff08Critical Path Initiative\uff09\uff0c\u9f13\u52b1\u5728\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u4f7f\u7528\u9002\u5e94\u6027\u8bbe\u8ba1\u7b49\u521b\u65b0\u65b9\u6cd5\uff0c\u4ee5\u5e94\u5bf9\u65e9\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u9ad8\u5931\u8d25\u7387\u548c\u5feb\u901f\u4e0a\u5347\u7684\u6210\u672c\u3002<\/p>\n\n\n\n

\u57282019\u5e7410\u6708\u7684Nature Review Drug Discovery\u6742\u5fd7\u4e0a\u53d1\u8868\u4e86\u4e00\u7bc7\u5173\u4e8e\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\u7684\u5b9a\u4e49\u3001\u8bbe\u8ba1\u3001\u5b9e\u65bd\u548c\u62a5\u544a\u7684\u51e0\u70b9\u8003\u8651\uff08Adaptive platform trials: definition, design, conduct and reporting considerations\uff09\u3002\u6587\u7ae0\u4e2d\u8be6\u7ec6\u8bb2\u89e3\u4e86\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\u4ece\u8bbe\u8ba1\u3001\u5b9e\u65bd\u5230\u7edf\u8ba1\u5b66\u5e94\u7528\u4e2d\u9700\u8981\u8003\u8651\u7684\u56e0\u7d20\u3002<\/p>\n\n\n\n

\"\"<\/figure><\/div>\n\n\n\n

<\/a><\/p>\n\n\n\n

\u4f17\u6240\u5468\u77e5\uff0c\u4f20\u7edf\u7684\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c\uff08RCT\uff09\u662f\u4e34\u5e8a\u7814\u7a76\u7684\u91d1\u6807\u51c6\uff0c\u4f46RCT\u901a\u5e38\u901f\u5ea6\u8f83\u6162\uff0c\u6548\u7387\u4f4e\u4e0b\uff0c\u4ec5\u5c40\u9650\u4e8e\u56de\u7b54\u65b9\u6848\u4e2d\u6240\u63d0\u5230\u7684\u95ee\u9898\uff0c\u4e14\u8bd5\u9a8c\u65b9\u6848\u4e00\u65e6\u786e\u5b9a\u540e\uff0c\u4e00\u822c\u4e0d\u518d\u505a\u8c03\u6574\u3002\u5f53\u610f\u8bc6\u5230\u4e86\u8fd9\u4e9b\u5c40\u9650\u6027\uff0c\u4e5f\u5f15\u53d1\u4e86\u7814\u7a76\u8005\u5bf9\u65b0\u9896\u7684\u8bd5\u9a8c\u8bbe\u8ba1\u7684\u5174\u8da3\u3002\u6700\u503c\u5f97\u6ce8\u610f\u7684\u662f\u4f7f\u7528\u4e00\u4e2a\u201c\u4e3b\u65b9\u6848\u201d\uff08master protocol\uff09\u7684\u65b9\u6848\u8bbe\u8ba1\uff0c\u5176\u4e2d\u9664\u4e86\u7bee\u5f0f\u8bd5\u9a8c\u3001\u4f1e\u5f0f\u8bd5\u9a8c\u4ee5\u5916\u8fd8\u6709\u4e00\u79cd\u4f7f\u7528master protocol\u7684\u521b\u65b0\u7814\u7a76\u6a21\u5f0f\uff0c\u79f0\u4e3a\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\uff08APTs\uff09\u3002\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\u4e0e\u4e3b\u65b9\u6848\u8bbe\u8ba1\u548c\u4f20\u7edfRCT\u4e09\u8005\u7684\u5173\u7cfb\u5982\u4e0b\u56fe\u6240\u793a\u3002<\/p>\n\n\n\n

\"\"<\/figure><\/div>\n\n\n\n

<\/a><\/p>\n\n\n\n

\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\u4e0e\u4f1e\u5f0f\u8bd5\u9a8c\u7c7b\u4f3c\uff0c\u90fd\u4e3a\u540c\u75c5\u5f02\u6cbb\u3002\u987e\u540d\u601d\u4e49\u4e5f\u5c31\u662f\u9488\u5bf9\u5355\u4e00\u75be\u75c5\u8fdb\u884c\u591a\u79cd\u5e72\u9884\u63aa\u65bd\u7684\u6548\u679c\u6bd4\u8f83\uff0c\u4f46\u4e24\u8005\u53c8\u6709\u4e0d\u540c\u3002\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\u662f\u968f\u7740\u65f6\u95f4\u7684\u63a8\u79fb\u800c\u8fdb\u884c\u7684\uff0c\u8bd5\u9a8c\u5468\u671f\u662f\u957f\u671f\u7684\u751a\u81f3\u662f\u6c38\u6052\u7684\uff0c\u6ca1\u6709\u56fa\u5b9a\u7684\u505c\u6b62\u65e5\u671f\uff0c\u5e72\u9884\u63aa\u65bd\u53ef\u4ee5\u6839\u636e\u4e3b\u7814\u7a76\u65b9\u6848\u7684\u51b3\u7b56\u89c4\u5212\u52a0\u5165\u6216\u79bb\u5f00\u5e73\u53f0\u8bd5\u9a8c\u3002<\/p>\n\n\n\n

\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\u8bbe\u8ba1\u4e2d\u4e5f\u52a0\u5165\u4e86\u8bd5\u9a8c\u5185\u5b66\u4e60\u4e0e\u81ea\u6211\u9002\u5e94\u6027\u7684\u8bbe\u8ba1\uff0c\u4f8b\u5982\uff1a\u57fa\u4e8e\u6548\u679c\u53cd\u5e94\u7684\u9002\u5e94\u6027\u968f\u673a\u5316\uff08RAR\uff09\uff0c\u6307\u7684\u662f\u5bf9\u65b0\u5165\u7ec4\u7684\u60a3\u8005\u8fdb\u884c\u968f\u673a\u5316\u7684\u65f6\u5019\uff0c\u5176\u968f\u673a\u6982\u7387\u4f9d\u8d56\u4e8e\u524d\u9762\u5df2\u968f\u673a\u60a3\u8005\u7684\u6548\u679c\u53cd\u5e94\u7ed3\u679c\u3002\u6548\u679c\u53cd\u5e94\u7684\u9002\u5e94\u6027\u968f\u673a\u5316\u5c06\u4f1a\u5236\u5b9a\u65b0\u5165\u7ec4\u7684\u60a3\u8005\u88ab\u4f18\u5148\u5206\u914d\u8fdb\u5165\u6cbb\u7597\u6548\u679c\u8f83\u597d\u7684\u5e72\u9884\u7ec4\u5185\u7684\u968f\u673a\u89c4\u5219\u3001\u89e6\u53d1\u6dfb\u52a0\u6216\u7ec8\u6b62\u7814\u7a76\u7ec4\u7684\u89c4\u5219\u3001\u6216\u4ece\u4e00\u4e2a\u8bd5\u9a8c\u9636\u6bb5\u5206\u7ea7\u8fdb\u5165\u4e0b\u4e00\u4e2a\u9636\u6bb5\u7684\u89c4\u5219\u3002\u6574\u4e2a\u8bd5\u9a8c\u6d41\u7a0b\u5982\u4e0b\u56fe\u6240\u793a\uff1a<\/p>\n\n\n\n

\"\"<\/figure><\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n

\u6587\u4e2d\u4e5f\u9488\u5bf9\u9002\u5e94\u6027\u5e73\u53f0\u8bd5\u9a8c\uff08ATP\uff09\u7684\u8bbe\u8ba1\u3001\u6587\u6863\u3001\u76d1\u7763\u548c\u62a5\u544a\u63d0\u51fa\u4e86\u4ee5\u4e0b\u5efa\u8bae\uff1a<\/p>\n\n\n\n

\"\"<\/figure><\/div>\n\n\n\n

<\/a><\/p>\n\n\n\n

\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0cAPT\u5e76\u4e0d\u662f\u4e00\u79cd\u4e07\u80fd\u7684\u8bd5\u9a8c\u8bbe\u8ba1\u3002\u5728\u5f88\u591a\u60c5\u51b5\u4e0bAPT\u4e0e\u4f20\u7edf\u8bd5\u9a8c\u8bbe\u8ba1\u76f8\u6bd4\u6216\u8bb8\u4e0d\u80fd\u63d0\u4f9b\u8db3\u591f\u7684\u7efc\u5408\u4f18\u52bf\u3002\u4f8b\u5982\uff0c\u5982\u679c\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u53ea\u9488\u5bf9\u4e24\u79cd\u7597\u6cd5\u4e4b\u95f4\u8fdb\u884c\u6bd4\u8f83\uff0cAPT\u5f80\u5f80\u4e0d\u4f1a\u5177\u6709\u660e\u663e\u7684\u4f18\u8d8a\u6027\u3002\u76f8\u4f3c\u7684\uff0c\u5982\u679c\u4e00\u9879\u8bd5\u9a8c\u5fc5\u987b\u7acb\u523b\u542f\u52a8\uff0c\u4e5f\u8bb8\u5e76\u6ca1\u6709APT\u6240\u9700\u7684\u3001\u8db3\u591f\u7684\u3001\u542f\u52a8\u524d\u7684\u51c6\u5907\u65f6\u95f4\u3002\u8003\u8651\u5230APT\u8bd5\u9a8c\u9700\u8981\u6df1\u601d\u719f\u8651\u7684\u65b9\u6848\u8bbe\u8ba1\u548c\u8017\u65f6\u7684\u542f\u52a8\u524d\u89c4\u5212\uff0c\u56e0\u6b64\u4e86\u89e3\u4f55\u65f6\u5e94\u8be5\u8003\u8651\u4f7f\u7528APT\u8bbe\u8ba1\u662f\u6781\u4e3a\u5173\u952e\u7684\u3002<\/p>\n\n\n\n

\u53c2\u8003\u6587\u732e\uff1a<\/span><\/em><\/p>\n\n\n\n

Adaptive Platform Trials Coalition. Adaptive platform trials: definition, design, conduct and reporting considerations. Nat Rev Drug Discov2019 Oct;18(10):797-807. doi: 10.1038\/s41573-019-0034-3. Epub 2019 Aug 28.<\/span><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

\u57282020\u5e7411\u67082\u65e5\u7684\u516c\u4f17\u53f7\u6587\u7ae0\u4e2d\uff0c\u6211\u4eec\u63d0\u5230\u4e86FDA\u6b63\u5f0f\u6279\u590d\u745e [\u2026]<\/span><\/p>\n","protected":false},"author":1,"featured_media":691,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/posts\/478"}],"collection":[{"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/comments?post=478"}],"version-history":[{"count":1,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/posts\/478\/revisions"}],"predecessor-version":[{"id":486,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/posts\/478\/revisions\/486"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/media\/691"}],"wp:attachment":[{"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/media?parent=478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/categories?post=478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cellauto.com\/cellauto\/wp-json\/wp\/v2\/tags?post=478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}